Skip to main content

Rockwell Medical Value Stock - Dividend - Research Selection

Rockwell Medical

ISIN: US7743741024, WKN: 916118

Market price date: 25.01.2021
Market price: 1,46 USD




Rockwell Medical Fundamental data and company key figures of the share

Annual reports in USD
Key figures 19-03-2020
Cash flow
Net operating cash flow -27.300.000
Capital Expenditures -587.452
Free cash flow -27.887.452
Balance sheet
Total Equity 20.319.500
Liabilities & Shareholders equity 44.316.500
Income statement
Net income -34.128.000
Eps (diluted) -0,560
Diluted shares outstanding 60.942.900
Net sales/revenue 61.302.800

Fundamental ratios calculated on: 25-01-2021

Ratios
Key figures 25-01-2021
Cash flow
P/C -3,17
   
P/FC -3,10
Balance sheet
ROI-77,01
ROE45,85
Income statement
P/E-2,61
Div. Yield0,00%
P/B4,26
P/S1,45


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolRMTI
Market Capitalization86.538.920,00 USD
CountryUnited States
IndicesNASDAQ Comp.
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.rockwellmed.com


Description of the company

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company\'s lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient\'s bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company\'s target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.rockwellmed.com